ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,961Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 617

$626K Total Retail Price of All Prescriptions

Rank: 42 out of 617

484 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,345 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 930 830 1 2
CARVEDILOL 863 806 2 19
OMEPRAZOLE 652 563 3 3
LEVOTHYROXINE SODIUM 465 400 4 1
LISINOPRIL 454 400 5 5
FUROSEMIDE 452 425 6 4
CITALOPRAM HBR 416 383 7 18
WARFARIN SODIUM 407 365 8 7
TRAMADOL HCL 343 298 9 15
METFORMIN HCL 304 267 10 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 302 302 11 29
AMLODIPINE BESYLATE 247 224 12 6
FLUTICASONE PROPIONATE 231 209 13 36
SERTRALINE HCL 184 145 14 20
AMITRIPTYLINE HCL 167 149 R 15 56
ALENDRONATE SODIUM 161 147 16 25
ZOLPIDEM TARTRATE 151 148 17 23
SPIRONOLACTONE 144 126 18 42
GABAPENTIN 142 113 19 16
LOSARTAN-HYDROCHLOROTHIAZIDE 134 118 20 46
TRAZODONE HCL 130 117 21 51
GLIMEPIRIDE 114 110 22 33
ROPINIROLE HCL 104 92 23 66
TERAZOSIN HCL 103 94 24 96
TRIAMCINOLONE ACETONIDE 103 91 24 102
WELCHOL 103 89 24 170
BENAZEPRIL HCL 102 102 27 44
POTASSIUM CHLORIDE 98 83 28 10
TAMSULOSIN HCL 88 76 29 26
HYDROCODONE-ACETAMINOPHEN 87 75 S3 30 8
SPIRIVA 86 86 31 61
QUETIAPINE FUMARATE 86 73 31 78
BYETTA 84 60 33 263
NAPROXEN 84 76 33 101
POLYETHYLENE GLYCOL 3350 83 69 35 32
VESICARE 81 81 36 95
ESCITALOPRAM OXALATE 79 73 37 65
SYMBICORT 79 72 37 141
AMLODIPINE BESYLATE-BENAZEPRIL 77 73 39 80
ALLOPURINOL 69 69 40 27
PREDNISONE 68 57 41 31
ADVAIR DISKUS 66 59 42 38
DONEPEZIL HCL 66 66 42 30
LANTUS 65 50 44 39
RANITIDINE HCL 59 36 45 40
LOSARTAN POTASSIUM 58 58 46 22
IBUPROFEN 57 27 47 140
AZITHROMYCIN 55 54 48 70
PHENYTOIN SODIUM EXTENDED 55 38 48 121
PROPRANOLOL HCL 55 49 48 109
DIOVAN 54 44 51 41
NEXIUM 52 40 52 43
CRESTOR 50 45 53 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.